½ÃÀ庸°í¼­
»óǰÄÚµå
1601110

Â÷¼¼´ë ÄÜÅÃÆ®·»Áî ¹× ½Ã°¢ º¸Á¶ ±â±¸ ½ÃÀå : Á¦Ç°º°, Áúȯº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Next Generation Contact Lenses & Visual Prostheses Market by Product, Disease - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 185 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Â÷¼¼´ë ÄÜÅÃÆ®·»Áî ¹× ½Ã°¢ º¸Á¶ ±â±¸ ½ÃÀåÀº 2023³â¿¡ 2¾ï 1,471¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í 2024³â¿¡´Â 2¾ï 5,445¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 18.76%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 7¾ï 1,557¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

Â÷¼¼´ë ÄÜÅÃÆ®·»Áî¿Í Àΰø ½Ã°¢±â ½ÃÀå¿¡´Â Àΰ£ ½Ã°¢À» °­È­, ȸº¹, È®ÀåÇϱâ À§Çؼ­ ¼³°èµÈ ½º¸¶Æ®ÇÏ°í ±â¼úÀûÀ¸·Î ÷´ÜÀåºñ°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ½Ã·Â Àå¾Ö À¯º´·ü Áõ°¡¿Í ½Ã·Â °­È­ ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ÀÇÇØ ÇʼöÀûÀÎ °ÍÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¿ëµµ´Â ±¼ÀýÀÌ»ó ±³Á¤À̳ª ´« °Ç°­ »óÅ ¸ð´ÏÅ͸µÀ¸·ÎºÎÅÍ, Áõ°­Çö½Ç üÇè Á¦°ø, ½Ã°¢ Àå¾ÖÀÎ ½Ã·Â ȸº¹±îÁö ´Ù¹æ¸é¿¡ °ÉĨ´Ï´Ù. ÃÖÁ¾ ¿ëµµ´Â ¼ÒºñÀÚ¿ë ±¤ÇÐ, ÇコÄɾî, ¿£ÅÍÅ×ÀÎ¸ÕÆ® ºÐ¾ß¿¡ À̸¨´Ï´Ù. ÁÖ¿ä ¼ºÀå¿äÀÎÀ¸·Î¼­´Â Àç·á °úÇÐ Áøº¸, ÀÏ·ºÆ®·Î´Ð½º ¼ÒÇüÈ­, ¾È°ú ¿¬±¸ ÀÚ±Ý Áõ°¡µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼¼°è Àα¸ °í·ÉÈ­¿Í ¾ÈÁúȯ ¹ß»ý·ü Áõ°¡°¡ ¼ö¿ä¸¦ ÇÑÃþ ´õ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú¿¡ AI¿Í IoT¸¦ ÅëÇÕÇØ, ÆÐ½º³Î¶óÀÌÁî µÈ ½Ã°¢ ¼Ö·ç¼ÇÀ» ±¸ÃàÇØ, ¾Æ½Ã¾ÆÅÂÆò¾ç °°Àº ¹Ì°³Ã´ Áö¿ª¿¡¼­ È®´ëÇÏ´Â »õ·Î¿î ±âȸ°¡ Á¸ÀçÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±âȸ¸¦ Æ÷ÂøÇϱâ À§ÇØ, ±â¾÷Àº Å×Å©³î·¯Áö ±â¾÷°úÀÇ Àü·«Àû ÆÄÆ®³Ê½Ê°ú ¿¬±¸°³¹ß¿¡ÀÇ Áö¼ÓÀû ÅõÀÚ¿¡ ÁÖ·Â ÇØ¾ß ÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 2¾ï 1,471¸¸ ´Þ·¯
¿¹Ãø ¿¬(2024) 2¾ï 5,445¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 7¾ï 1,557¸¸ ´Þ·¯
CAGR(%) 18.76%

±×·¯³ª, ½ÃÀå ¼ºÀåÀº ³ôÀº ¿¬±¸°³¹ßºñ, º¹ÀâÇÑ ±ÔÁ¦±â°ü ½ÂÀÎ ÇÁ·Î¼¼½º, »ðÀÔÇü ±â±â¸¦ µÑ·¯½Î´Â ÀáÀçÀûÀÎ À±¸®Àû ¿ì·ÁµîÀÇ °úÁ¦¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ »ç¿ëÀÚ ¾ÈÀü¼ºÀ̳ª ½Å±â¼ú Àå±âÀû ¿µÇâ¿¡ °üÇÑ ¿ì·Áµµ ÀÖ½À´Ï´Ù. ¾ö¹ÐÇÑ ÀÓ»ó½ÃÇèÀ» ÅëÇØ¼­ ÀÌ·¯ÇÑ ¹®Á¦¿¡ ´ëÃ³ÇØ, ÄÜÅÃÆ®·»Á Àΰø Àåºñ »ýü ÀûÇÕ¼ºÀ̳ª ÄèÀû¼ºÀ» °³¼±ÇÏ´Â °ÍÀ¸·Î, Çõ½ÅÀº ¹ßÀüÇÒ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. Áõ°­Çö½Ç, ¹ÙÀÌ¿À´Ð ºñÀü ½Ã½ºÅÛ, ·»Áî¿¡ ÆÄ¹¯Èù ¹ÙÀÌ¿À¼¾¼­µîÀÇ Çõ½ÅÀ» ޱ¸ÇÏ´Â °ÍÀ¸·Î, ½ÃÀå Å« Break through·Î ¿¬°áµÉ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. Á¶»ç´Â ÇコÄÉ¾î ¿ëµµÀ» À§ÇÑ ½º¸¶Æ® ·»Áî·ÎºÎÅÍ µ¥ÀÌÅÍ Áý¾à °³¼±°ú Áõ°­Çö½Ç ÀÎÅÍÆäÀ̽º¿¡ ÀÇÇÑ »ç¿ëÀÚ ÀÎÅÍ·¢¼Ç °­È­¸¦ ¸ñÇ¥·Î ÇØ¾ß ÇÕ´Ï´Ù. ½ÃÀåÀº ´ÙÀ̳ª¹ÍÇÏ°í °æÀïÀÌ °Ý·ÄÇϰí, ±Þ¼ÓÇÑ ±â¼ú Çõ½Å°ú °í¾× ¿¬±¸°³¹ß ÅõÀÚ°¡ Ư¡ÀÔ´Ï´Ù. ±â¾÷Àº ÁøÈ­ÇÏ´Â ±ÔÁ¦ »óȲÀ̳ª ¼ÒºñÀÚ ±â´ë¿¡ ÀûÀÀÇÒ Çʿ䰡 ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀå¿¡¼­ÀÇ ¼º°øÀº ±â¼ú Çõ½Å°ú À±¸®Àû¡¤±ÔÁ¦Àû ¹è·Á ¹ë·±½º¸¦ Àâ¾Æ, ½ÅÁ¦Ç°ÀÌ ¾ÈÀüÇϰí È¿°úÀûÀ¸·Î, »ç¿ëÀÚ ¿ä±¸¸¦ ä¿ì´Â °ÍÀ» È®½ÇÈ÷ ÇÏ´Â °Í¿¡ °É·Á ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ : ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â Â÷¼¼´ë ÄÜÅÃÆ®·»Áî ¹× ½Ã°¢ º¸Á¶ ±â±¸ ½ÃÀå ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® ÇØ¸í

Â÷¼¼´ë ÄÜÅÃÆ®·»Áî ¹× ½Ã°¢ º¸Á¶ ±â±¸ ½ÃÀåÀº ¼ö¿ä ¹× °ø±Þ ´ÙÀ̳ª¹ÍÇÑ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ¼­ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐ ÁøÈ­¸¦ ÀÌÇØÇÏ´Â °ÍÀ¸·Î, ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¿¡ ±Ù°ÅÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæÀ» ½Ç½ÃÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÏ´Â °ÍÀ¸·Î, ±â¾÷Àº Á¤Ä¡Àû, Áö¿ª ¸ñÇ¥, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °Ç³Ê°¡´Â ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖ¾î ¶ÇÇÑ ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ëÀ̳ª ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¸Á¸· »ö¼Ò º¯¼º, Ȳ¹Ýº¯¼º, ³ì³»Àå, ¹é³»ÀåµîÀÇ ¾ÈÁúȯ Áõ°¡
    • ³­½Ã ȯÀÚ Áõ°¡¿¡ ÀÇÇÑ ÇÏÀ̺긮µå ÄÜÅÃÆ®·»Áî º¸±Þ·ü »ó½Â
    • º¸Ã¶¸ñÀûÀ¸·Î ½Å°æ°è¿Í ÀÎÅÍÆäÀ̽º ÇÏ´Â µð¹ÙÀ̽º³ª Åø °³¹ß
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±¼Àý ±³Á¤ ¼ö¼ú ¼ö¶ô È®´ë
  • ½ÃÀå ±âȸ
    • ±â¼ú Áøº¸¿Í »õ·Î¿î »ýü Àç·á °¡¿ë¼º
    • ´Ù¾çÇÑ ¾ÈÁúȯ ¹ÙÀÌ¿À ¼¾½ÌÀ¸·Î Áø´Ü ÄÜÅÃÆ®·»Áî ÀÀ¿ë °¡´É¼º
  • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
    • ÇÁ·Î Á¤¸³ »ðÀÔ¿¡ ¼ö¹ÝÇÏ´Â º¹À⼺

Porter's Five Forces : Â÷¼¼´ë ÄÜÅÃÆ®·»Áî ¹× ½Ã°¢ º¸Á¶ ±â±¸ ½ÃÀåÀ» ¾È³»ÇÏ´Â Àü·« Åø

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå ±¸µµ °æÀï ±¸µµ¸¦ ÀÌÇØÇϱâ À§ÇÑ Áß¿ä ÅøÀÔ´Ï´Ù. Porter's Five Forces¡¤ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ °æÀï·ÂÀ» Æò°¡ÇØ, Àü·«Àû ±âȸ¸¦ ã±â À§ÇÑ ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå³» ¼¼·Âµµ¸¦ Æò°¡ÇØ, ½Å±Ô »ç¾÷ ¼öÀͼºÀ» ÆÇ´ÜÇϴµ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû¿¡ ÀÇÇØ ±â¾÷Àº ÀÚ»ç °­Á¡À» »ì·Á, ¾àÁ¡¿¡ ´ëÃ³ÇØ, ÀáÀçÀûÀÎ °úÁ¦¸¦ ȸÇÇÇÒ ¼ö À־´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Â÷¼¼´ë ÄÜÅÃÆ®·»Áî ¹× ½Ã°¢ º¸Á¶ ±â±¸ ½ÃÀå ¿ÜºÎ·ÎºÎÅÍ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ãȯ°æ ¿äÀÎÀº Â÷¼¼´ë ÄÜÅÃÆ®·»Áî ¹× ½Ã°¢ º¸Á¶ ±â±¸ ½ÃÀå ½ÇÀû ¿ªÇÐÀ» Çü¼ºÇϴµ¥ À־ ¸Å¿ì Áß¿ä ¿ªÇÒÀ» ¿Ï¼öÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» ¾È³»Çϱâ À§Çؼ­ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÏ´Â °ÍÀ¸·Î, ±â¾÷Àº ÀáÀçÀûÀÎ ¸®½ºÅ©¿Í ±âȸ¸¦ º¸´Ù ÁÁ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®¿¡ ÀÇÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿Çâ º¯È­¸¦ ¿¹ÃøÇØ, ¾ÕÀ» ¿¹ÃøÇÑ Àû±ØÀûÀÎ ÀÇ»ç°áÁ¤À» ½Ç½ÃÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® Â÷¼¼´ë ÄÜÅÃÆ®·»Áî ¹× ½Ã°¢ º¸Á¶ ±â±¸ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

Â÷¼¼´ë ÄÜÅÃÆ®·»Áî ¹× ½Ã°¢ º¸Á¶ ±â±¸ ½ÃÀå »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®¿¡ ÀÇÇØ º¥´õ ½ÇÀûÀ» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¸ÅÃâ, °í°´ ±â¹Ý, ¼ºÀå·üµîÀÇ ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ´Â °ÍÀ¸·Î, °æÀï»ó Æ÷Áö¼Å´×À» ºÐ¸íÈ÷ ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®¿¡ ÀÇÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀÌ ¹àÇôÁ®, º¥´õ´Â °æÀïÀÌ °ÝÈ­ÇÏ´Â °¡¿îµ¥ ÀÚ»ç ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ½Ç½ÃÇϱâ À§Çؼ­ ÇÊ¿äÇÑ Áö°ßÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º Â÷¼¼´ë ÄÜÅÃÆ®·»Áî ¹× ½Ã°¢ º¸Á¶ ±â±¸ ½ÃÀå º¥´õ ÆÛÆ÷¸Õ½º Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Â÷¼¼´ë ÄÜÅÃÆ®·»Áî ¹× ½Ã°¢ º¸Á¶ ±â±¸ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡Çϱâ À§ÇÑ Áß¿ä ÅøÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¿¡ ÀÇÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¿¡ ±Ù°ÅÇØ Æò°¡ÇÏ´Â °ÍÀ¸·Î, ¸ñÇ¥¿¡ µû¸¥ ÃæºÐÇÑ Á¤º¸¿¡ ±Ù°ÅÇÑ ÀÇ»ç°áÁ¤À» ½Ç½ÃÇÒ ¼ö ÀÖ½À´Ï´Ù. 4°³ »óÇÑÀº º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ±¸ºÐÇØ, »ç¿ëÀÚ°¡ Àü·« ¸ñÇ¥·Î ÃÖÀûÀÎ ÆÄÆ®³Ê³ª ¼Ö·ç¼ÇÀ» ƯÁ¤Çϴµ¥ µµ¿òÀÌ µË´Ï´Ù.

º» º¸°í¼­´Â ÁÖ¿ä ÁÖ¸ñ ºÐ¾ß¸¦ ¸Á¶óÇÑ Á¾ÇÕÀû½ÃÀå ºÐ¼®À» Á¦°øÇϰí ÀÖ½À´Ï´Ù :

1.½ÃÀå ħÅõµµ : ¾÷°è ÁÖ¿ä ±â¾÷ ±¤¹üÀ§ÇÑ µ¥ÀÌÅ͸¦ Æ÷ÇÔÇÑ ÇöÀç ½ÃÀå ȯ°æ »ó¼¼ÇÑ ¸®ºä.

2.½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀå ¼ºÀå ±âȸ¸¦ ƯÁ¤ÇØ, ±âÁ¸ ºÐ¾ß È®´ë °¡´É¼ºÀ» Æò°¡ÇØ, ÇâÈÄ ¼ºÀåÀ» ÇâÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3.½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° ¹ß¸Å, ¹Ì°³Ã´ Áö¿ª, ¾÷°è ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4.°æÀï Æò°¡¿Í Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÇÏ°Ô ºÐ¼®ÇÏ°í ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦±â°ü ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ ±â¼ú Áøº¸µîÀ» °ËÁõ ÇÕ´Ï´Ù.

5.Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÑ´Ù°í ±â´ëµÇ´Â ÃÖ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿, Á¦Ç° Çõ½ÅÀ» ÇÏÀ̶óÀÌÆ® Çϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾òÀº ´ÙÀ½ ÀÇ»ç°áÁ¤ ÇÒ ¼ö ÀÖµµ·Ï, Áß¿ä Áú¹®¿¡µµ ´äÇϰí ÀÖ½À´Ï´Ù :

1.ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2.ÃÖ°í ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº ¾îµò°¡?

3.½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ ¿µÇâÀ̶õ?

4.ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå Âü¿©¡¤Ã¶Åð Àü·« ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÔ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå Â÷¼¼´ë ÄÜÅÃÆ®·»Áî ¹× ½Ã°¢ º¸Á¶ ±â±¸ ½ÃÀå : Á¦Ç°º°

  • Áø´Ü¿ë ¶Ç´Â ¸ð´ÏÅ͸µ¿ë ÄÜÅÃÆ®·»Áî
  • ¾àÁ¦¿ëÃâ ÄÜÅÃÆ®·»Áî
  • Ä¡·á¿ë ÄÜÅÃÆ®·»Áî
  • ½Ã°¢ º¸Á¶ ±â±¸
    • ÇÇÁú ÀÓÇöõÆ®
    • ½Ã½Å°æ ÀÓÇöõÆ®
    • ¸Á¸· À̽Ä

Á¦7Àå Â÷¼¼´ë ÄÜÅÃÆ®·»Áî ¹× ½Ã°¢ º¸Á¶ ±â±¸ ½ÃÀå : Áúȯº°

  • ³ëÀμº Ȳ¹Ýº¯¼º
  • ´ç´¢º´
  • ³ì³»Àå
  • ¸Á¸· »ö¼Ò º¯¼ºÁõ

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ Â÷¼¼´ë ÄÜÅÃÆ®·»Áî ¹× ½Ã°¢ º¸Á¶ ±â±¸ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Â÷¼¼´ë ÄÜÅÃÆ®·»Áî ¹× ½Ã°¢ º¸Á¶ ±â±¸ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Â÷¼¼´ë ÄÜÅÃÆ®·»Áî ¹× ½Ã°¢ º¸Á¶ ±â±¸ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®

±â¾÷ ¸®½ºÆ®

  • ABB Optical Group
  • Alcon Vision LLC
  • Bausch & Lomb Incorporated
  • Bionic Vision Technologies
  • Chromagen Europe B.V.
  • CooperVision, Inc.
  • HOYA Corporation
  • INTEROJO CO. LTD.
  • Johnson & Johnson Vision Care, Inc.
  • Luneau Technology Operations SAS
  • Menicon Co., Ltd.
  • Miami Contact Lens
  • Mojo Vision Inc.
  • Nidek Co., Ltd.
  • Novartis AG
  • Orion Vision Group
  • PERVICE CO., LTD.
  • Pixium Vision SA
  • Sensimed SA
  • Spectrum International
  • STAAR Surgical Company
  • SwissLens S.A.
  • SynergEyes, Inc.
  • XPANCEO RESEARCH ON NATURAL SCIENCE L.L.C.
  • ZEISS Group
LSH 24.12.06

The Next Generation Contact Lenses & Visual Prostheses Market was valued at USD 214.71 million in 2023, expected to reach USD 254.45 million in 2024, and is projected to grow at a CAGR of 18.76%, to USD 715.57 million by 2030.

The market for next-generation contact lenses and visual prostheses encompasses smart, technologically advanced devices designed to enhance, restore, or augment human vision. These innovations are essential due to the growing prevalence of vision impairment and the increasing demand for vision-enhancing technologies. Applications range from correcting refractive errors and monitoring ocular health to providing augmented reality experiences and restoring sight for visually impaired individuals. End-use spans across consumer optics, healthcare, and entertainment sectors. Key growth factors include advancements in material science, miniaturization of electronics, and increased funding in ophthalmic research. Moreover, an aging global population and the increasing incidence of ocular diseases further drive demand. Emerging opportunities exist in integrating AI and IoT within these technologies, creating personalized vision solutions, and expanding in untapped regions like Asia-Pacific. To capture these opportunities, businesses should focus on strategic partnerships with technology firms and continuous investment in R&D.

KEY MARKET STATISTICS
Base Year [2023] USD 214.71 million
Estimated Year [2024] USD 254.45 million
Forecast Year [2030] USD 715.57 million
CAGR (%) 18.76%

However, market growth faces challenges, such as high R&D costs, complex regulatory approval processes, and potential ethical concerns surrounding implantable devices. Additionally, there are concerns regarding user safety and long-term effects of new technologies. Innovations can thrive by addressing these issues through rigorous clinical trials and improving biocompatibility and comfort of contact lenses and prostheses. Exploring innovations in augmented reality, bionic vision systems, and biosensors embedded in lenses could lead to significant market breakthroughs. Research should aim at improving data aggregation from smart lenses for healthcare applications and enhancing user interaction with augmented reality interfaces. The market is dynamic and competitive, characterized by rapid technological change and significant R&D investments. Companies need to adapt to evolving regulatory landscapes and consumer expectations. Success in this market will depend on balancing innovation with ethical and regulatory considerations, ensuring that new products are safe, effective, and meet user needs.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Next Generation Contact Lenses & Visual Prostheses Market

The Next Generation Contact Lenses & Visual Prostheses Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in Ocular Diseases such as Retinitis Pigmentosa, Macular Degeneration, Glaucoma, and Cataract
    • Growing Prevalence of Hybrid Contact Lenses owing to Rising Cases of Astigmation
    • Development of Devices and Tools to Interface with The Nervous System for Prosthetic Purposes
  • Market Restraints
    • Growing Acceptance of Refractive Surgeries
  • Market Opportunities
    • Technological Advances and the Availability of New Biomaterials
    • Potential Application of the Contact Lenses in the Biosensing and Diagnosis of Various Ocular Disorders
  • Market Challenges
    • Complexities Associated with the Prosthesis Implantation

Porter's Five Forces: A Strategic Tool for Navigating the Next Generation Contact Lenses & Visual Prostheses Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Next Generation Contact Lenses & Visual Prostheses Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Next Generation Contact Lenses & Visual Prostheses Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Next Generation Contact Lenses & Visual Prostheses Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Next Generation Contact Lenses & Visual Prostheses Market

A detailed market share analysis in the Next Generation Contact Lenses & Visual Prostheses Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Next Generation Contact Lenses & Visual Prostheses Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Next Generation Contact Lenses & Visual Prostheses Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Next Generation Contact Lenses & Visual Prostheses Market, highlighting leading vendors and their innovative profiles. These include ABB Optical Group, Alcon Vision LLC, Bausch & Lomb Incorporated, Bionic Vision Technologies, Chromagen Europe B.V., CooperVision, Inc., HOYA Corporation, INTEROJO CO. LTD., Johnson & Johnson Vision Care, Inc., Luneau Technology Operations SAS, Menicon Co., Ltd., Miami Contact Lens, Mojo Vision Inc., Nidek Co., Ltd., Novartis AG, Orion Vision Group, PERVICE CO., LTD., Pixium Vision SA, Sensimed SA, Spectrum International, STAAR Surgical Company, SwissLens S.A., SynergEyes, Inc., XPANCEO RESEARCH ON NATURAL SCIENCE L.L.C., and ZEISS Group.

Market Segmentation & Coverage

This research report categorizes the Next Generation Contact Lenses & Visual Prostheses Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Diagnostic or monitoring contact lenses, Drug-eluting contact lenses, Therapeutic contact lenses, and Visual prostheses. The Visual prostheses is further studied across Cortical Implant, Optic Nerve Implant, and Retinal Implant.
  • Based on Disease, market is studied across Age-Related Macular Degeneration, Diabetes, Glaucoma, and Retinitis pigmentosa.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in Ocular Diseases such as Retinitis Pigmentosa, Macular Degeneration, Glaucoma, and Cataract
      • 5.1.1.2. Growing Prevalence of Hybrid Contact Lenses owing to Rising Cases of Astigmation
      • 5.1.1.3. Development of Devices and Tools to Interface with The Nervous System for Prosthetic Purposes
    • 5.1.2. Restraints
      • 5.1.2.1. Growing Acceptance of Refractive Surgeries
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological Advances and the Availability of New Biomaterials
      • 5.1.3.2. Potential Application of the Contact Lenses in the Biosensing and Diagnosis of Various Ocular Disorders
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities Associated with the Prosthesis Implantation
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Burgeoning adoption of therapeutic contact lenses proving invaluable in post-surgical care and treatment of various corneal conditions
    • 5.2.2. Disease: Evolving adoption of next-generation contact lenses and visual prostheses for age-related macular degeneration
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization
    • 5.5.1. Impact Analysis
    • 5.5.2. Regulatory Framework

6. Next Generation Contact Lenses & Visual Prostheses Market, by Product

  • 6.1. Introduction
  • 6.2. Diagnostic or monitoring contact lenses
  • 6.3. Drug-eluting contact lenses
  • 6.4. Therapeutic contact lenses
  • 6.5. Visual prostheses
    • 6.5.1. Cortical Implant
    • 6.5.2. Optic Nerve Implant
    • 6.5.3. Retinal Implant

7. Next Generation Contact Lenses & Visual Prostheses Market, by Disease

  • 7.1. Introduction
  • 7.2. Age-Related Macular Degeneration
  • 7.3. Diabetes
  • 7.4. Glaucoma
  • 7.5. Retinitis pigmentosa

8. Americas Next Generation Contact Lenses & Visual Prostheses Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Next Generation Contact Lenses & Visual Prostheses Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Next Generation Contact Lenses & Visual Prostheses Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. New High-Tech Startup Developing Smart Contact Lenses for Glaucoma Diagnosis and Management
    • 11.3.2. MAHE Researchers Develop Self-Moisturising Contact Lens
    • 11.3.3. Johnson & Johnson Vision Care Receives FDA Approval for ACUVUE Theravision with Ketotifen - Drug-Eluting Contact Lens

Companies Mentioned

  • 1. ABB Optical Group
  • 2. Alcon Vision LLC
  • 3. Bausch & Lomb Incorporated
  • 4. Bionic Vision Technologies
  • 5. Chromagen Europe B.V.
  • 6. CooperVision, Inc.
  • 7. HOYA Corporation
  • 8. INTEROJO CO. LTD.
  • 9. Johnson & Johnson Vision Care, Inc.
  • 10. Luneau Technology Operations SAS
  • 11. Menicon Co., Ltd.
  • 12. Miami Contact Lens
  • 13. Mojo Vision Inc.
  • 14. Nidek Co., Ltd.
  • 15. Novartis AG
  • 16. Orion Vision Group
  • 17. PERVICE CO., LTD.
  • 18. Pixium Vision SA
  • 19. Sensimed SA
  • 20. Spectrum International
  • 21. STAAR Surgical Company
  • 22. SwissLens S.A.
  • 23. SynergEyes, Inc.
  • 24. XPANCEO RESEARCH ON NATURAL SCIENCE L.L.C.
  • 25. ZEISS Group
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦